Utility of Obtaining a Serum Basic Metabolic Panel in the Setting of a First-Time Nonfebrile Seizure

Britton D Zuccarelli1, Ara S Hall2

  • 1Children's Mercy, Kansas City, MO, USA bzuccarelli@cmh.edu.

Clinical Pediatrics
|January 27, 2016
PubMed

Insights

New-onset nonfebrile seizures in children are common. Electrolyte disturbances like hyponatremia are unlikely in healthy children experiencing a first-time seizure without concerning symptoms.

Area of Science:

  • Pediatric Neurology
  • Clinical Chemistry

Background:

  • New-onset nonfebrile seizures affect a significant number of U.S. children annually.
  • Electrolyte disturbances are potential causes of seizures, but their prevalence in healthy children with first-time seizures is not well-established.

Purpose of the Study:

  • To investigate the frequency of seizure-provoking electrolyte disturbances (hyponatremia, hypoglycemia, hypocalcemia) in children presenting with new-onset nonfebrile seizures.
  • To determine if electrolyte abnormalities are common in otherwise healthy children after a first-time nonfebrile seizure.

Main Methods:

  • Retrospective review of 358 children (29 days to 18 years) diagnosed with "other convulsions" (ICD-9 code 780.39) between January 1, 2009, and May 31, 2009.
  • Exclusion of children with known epilepsy or febrile seizures.
  • Analysis of electrolyte levels (sodium, glucose, calcium) in children with and without concerning histories or physical examinations.

Main Results:

  • Electrolyte levels were assessed in 13 of 14 children (93%) with concerning histories and 62 of 119 children (52%) with reassuring histories.
  • No child with an unremarkable history and physical examination exhibited electrolyte abnormalities below seizure-associated thresholds.
  • Electrolyte disturbances were found to be uncommon in this cohort.

Conclusions:

  • Electrolyte abnormalities are unlikely to be the cause of new-onset nonfebrile seizures in otherwise well-appearing children.
  • Routine electrolyte testing may not be necessary for all children presenting with a first-time nonfebrile seizure and a normal examination.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.1K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
605
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K